Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Guardian - UK
The Guardian - UK
Politics
Nicola Davis Science correspondent

People using drug Mounjaro sustain weight loss over three years, trial finds

A pharmacist holds a box of Mounjaro
The results of the study, to be presented at European Congress on Obesity in Málaga next month, have yet to be peer reviewed. Photograph: George Frey/Reuters

People who use the drug Mounjaro are able to sustain weight loss for three years, data from a trial suggests.

Mounjaro, nicknamed the “King Kong” of weight loss drugs, contains tirzepatide and is self-administered in once-a-week injections.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.